Danieli O. De Andrade
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry study.
Journal: Rheumatology (Oxford, England)
Published: February 11, 2026
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry").
Journal: Lupus
Published: April 03, 2025
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry").
Journal: Seminars in arthritis and rheumatism
Published: May 17, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 30, 2022
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus.
Journal: Arthritis care & research
Published: September 07, 2021
The role of antirheumatics in patients with COVID-19.
Journal: The Lancet. Rheumatology
Published: April 05, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026